Evidence map›Paper›PMID 33071677›Full record

ArticleJournal of interventional cardiology2020

Bivalirudin vs. Heparin on Radial Artery Thrombosis during Transradial Coronary Intervention: An Optical Coherence Tomography Study.

Zijing Liu, Guozhong Wang, Dan Niu, Yongxia Wu, Zixuan Li, Libin Zhang, Guohua Zhu, Qi Hua, Jincheng Guo

Open access · goldAbstract read
In one paragraph

Article in Journal of interventional cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Zijing LiuDepartment of Cardiology, Xuanwu Hospital, Capital Medical University, Beijing 10000, China.
Guozhong WangDepartment of Cardiology, Beijing Luhe Hospital, Capital Medical University, Beijing 100000, China.
Dan NiuDepartment of Cardiology, Beijing Luhe Hospital, Capital Medical University, Beijing 100000, China.
Yongxia WuDepartment of Cardiology, Beijing Luhe Hospital, Capital Medical University, Beijing 100000, China.
Zixuan LiDepartment of Cardiology, Beijing Luhe Hospital, Capital Medical University, Beijing 100000, China.
Libin ZhangDepartment of Cardiology, Beijing Luhe Hospital, Capital Medical University, Beijing 100000, China.
Guohua ZhuDepartment of Cardiology, Xuanwu Hospital, Capital Medical University, Beijing 10000, China.
Qi HuaDepartment of Cardiology, Xuanwu Hospital, Capital Medical University, Beijing 10000, China.ORCID https://orcid.org/0000-0002-5115-2149
Jincheng GuoDepartment of Cardiology, Beijing Luhe Hospital, Capital Medical University, Beijing 100000, China.ORCID https://orcid.org/0000-0001-6173-6386
Beijing Luhe Hospital Affiliated to Capital Medical University · CNCapital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aimed to evaluate the antithrombotic efficacy between bivalirudin and unfractionated heparin (UFH) on radial artery thrombosis (RAT) during transradial coronary intervention (TRI) by optical coherence tomography (OCT). METHODS AND

resultsWe consecutively reviewed a total of 307 patients who underwent radial artery OCT inspection after TRI in our centre from October 2017 to January 2019; afterwards, 211 screened patients were divided into the UFH group (

conclusionIn this present study, the use of bivalirudin was associated with a higher risk of RAT than UFH. It highlighted UFH should be a more considerable choice to prevent radial artery access thrombosis in TRI.

Indexed as

HeparinHirudinsPeptide FragmentsPercutaneous Coronary InterventionRadial ArteryThrombosisCatheterization, PeripheralFemaleFibrinolytic AgentsHumansMaleMiddle AgedRecombinant ProteinsRisk AdjustmentTomography, Optical CoherenceTreatment OutcomebivalirudinFibrinolytic AgentsHeparinHirudinsPeptide FragmentsRecombinant Proteins

Identifiers

PMID33071677
PMCPMC7533783
OpenAlexW3088119630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.